Our Manufacturing Facility
Contura’s state-of-the-art manufacturing facility in Denmark has over 20 years of experience
producing 2.5% iPAAG* injectables. It is certified according to EU, US and other international
standards, using proprietary technology and stringent quality control measures to deliver
the highest quality products.
Solely dedicated to the production of 2.5% iPAAG, the facility uses proprietary automated processes to control manufacturing,
including the ALPH (Automated Line for Production of Hydrogel), a one-of-a-kind machine designed specifically for Contura.
ALPH’s advanced capabilities and design reflect our commitment to innovation and excellence in hydrogel production.
We have a team of highly qualified scientists and engineers who oversee the production process and ensure our syringes
are tightly monitored to meet release specifications.